课题基金 / 基金详情

Safety Evaluation of Anti-Infective Agents

Safety Evaluation of Anti-Infective Agents
抗感染药物的安全性评价
批准号:
8540325
负责人:
Jon Carl Mirsalis
金额:
$234.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2013-09-29

项目摘要

项目成果

Jon Carl Mirsalis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of this contract is to support the NIAID in its mission to develop safe and effective therapies for the treatment of infectious diseases caused by Human Immunodeficiency Virus (HIV), Mycobacterium tuberculosis, Plasmodium sp., opportunistic pathogens that infect AIDS patients, and others. The NIAID requires a Safety Evaluation Contract to assess the health and safety potential of new therapies under development by, or with the support of, the Division of AIDS, NIAID. The scope of this effort is to evaluate the toxicity and pharmacokinetics of potential chemical and biological therapies for AIDS and other infectious diseases in various laboratory animal species.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task Order 3: Interventional Agent Development Services Program
  • 批准号:
    10704968
  • 项目类别:
  • 资助金额:
    $1.17万
  • 财政年份:
    2018
  • 负责人:
    Jon Carl Mirsalis
  • 依托单位:
Task Order 3:Interventional Agent Development Services Program
  • 批准号:
    9452777
  • 项目类别:
  • 资助金额:
    $47.24万
  • 财政年份:
    2017
  • 负责人:
    Jon Carl Mirsalis
  • 依托单位:
Task Order 5: The Interventional Agent Development Services Program
  • 批准号:
    9616145
  • 项目类别:
  • 资助金额:
    $8.95万
  • 财政年份:
    2017
  • 负责人:
    Jon Carl Mirsalis
  • 依托单位:
Task 4: The Interventional Agent Development Services program
  • 批准号:
    9430224
  • 项目类别:
  • 资助金额:
    $191.89万
  • 财政年份:
    2017
  • 负责人:
    Jon Carl Mirsalis
  • 依托单位:
海外基金